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Abstract: AIM To assess histopathological and histomorphometric outcomes of soft tissue volume aug-
mentation procedures at pontic sites using a volume-stable cross-linked collagen matrix (VCMX) and a
non-cross-linked collagen matrix (XCM). MATERIALS AND METHODS In twelve adult beagle dogs,
the mandibular premolars and first molar were hemisected and the mesial root extracted. Soft tissue
augmentation was randomly performed using VCMX, XCM, or a sham-operated control. Sacrifice was
performed after 4, 8, and 26 weeks. Non-decalcified sections were analyzed for histopathologic and
histomorphometric measurements at four different levels below the crest (1.5, 2.5, 3.5, and 5.5 mm).
RESULTS Group VCMX presented a greater overall amount of soft tissue at all healing time points,
more pronounced fibroblast ingrowth, vascularization, and a substantial new collagen deposition. Over
time, group XCM demonstrated faster signs of degradation compared with group VCMX. Four weeks
after augmentation, group VCMX yielded a higher mean ridge width compared with groups XCM (2.22
mm VCMX, 0.89 mm XCM (at 2.5 mm); 2.05 mm VCMX, 0.80 mm XCM (at 3.5 mm) p < 0.05) and
sham (0.59 mm sham (at 1.5 mm); 0.48 mm (at 2.5 mm); 0.44 mm (at 3.5 mm) p < 0.05). After healing
periods of 8 and 26 weeks, measurements in group VCMX remained significantly higher compared with
group sham both at 8 weeks (levels of 1.5 mm, 2.5 mm and 5.5 mm) and at 26 weeks (levels of 1.5 mm,
3.5 mm and 5.5 mm) (p < 0.05). CONCLUSION The use of a cross-linked collagen matrix resulted in a
greater and more stable ridge width over time compared with control groups. CLINICAL RELEVANCE
Soft tissue volume augmentation at pontic sites is more effective when using a cross-linked compared
with a non-cross-linked collagen matrix.
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Abstract
Aim To assess histopathological and histomorphometric outcomes of soft tissue volume augmentation procedures at pontic sites
using a volume-stable cross-linked collagen matrix (VCMX) and a non-cross-linked collagen matrix (XCM).
Materials and methods In twelve adult beagle dogs, the mandibular premolars and first molar were hemisected and the mesial
root extracted. Soft tissue augmentation was randomly performed using VCMX,XCM, or a sham-operated control. Sacrifice was
performed after 4, 8, and 26 weeks. Non-decalcified sections were analyzed for histopathologic and histomorphometric mea-
surements at four different levels below the crest (1.5, 2.5, 3.5, and 5.5 mm).
Results Group VCMX presented a greater overall amount of soft tissue at all healing time points, more pronounced fibroblast
ingrowth, vascularization, and a substantial new collagen deposition. Over time, group XCM demonstrated faster signs of
degradation compared with group VCMX. Four weeks after augmentation, group VCMX yielded a higher mean ridge width
compared with groups XCM (2.22 mm VCMX, 0.89 mm XCM (at 2.5 mm); 2.05 mm VCMX, 0.80 mm XCM (at 3.5 mm)
p < 0.05) and sham (0.59 mm sham (at 1.5 mm); 0.48 mm (at 2.5 mm); 0.44 mm (at 3.5 mm) p < 0.05). After healing periods of 8
and 26 weeks, measurements in group VCMX remained significantly higher compared with group sham both at 8 weeks (levels
of 1.5 mm, 2.5 mm and 5.5 mm) and at 26 weeks (levels of 1.5 mm, 3.5 mm and 5.5 mm) (p < 0.05).
Conclusion The use of a cross-linked collagen matrix resulted in a greater and more stable ridge width over time compared with
control groups.
Clinical relevance Soft tissue volume augmentation at pontic sites is more effective when using a cross-linked compared with a
non-cross-linked collagen matrix.
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Introduction
Resorption and remodeling processes of the ridge after tooth
extraction cannot be circumvented and often result in contour
and volume deficits after healing [1]. In order to re-establish
the ridge contour, to optimize esthetics, and to simplify clean-
ability, soft tissue grafting procedures were proposed at future
implant and pontic sites [2–4]. Soft tissue augmentation
procedures are therefore performed to improve the tissue qual-
ity (gain of keratinized tissue) or the tissue quantity (volume
increase). Traditionally, autogenous grafts harvested from the
patient’s palate represent the gold standard [5]. The main dis-
advantage of these procedures is represented by the second
surgical site which is the main cause for post-surgical bleed-
ing, increased treatment time, and increased patient morbidity
[6–8]. Consequently, the development of substitute materials
serving as alternatives for autogenous grafts has been the fo-
cus of research over the past 10 years. Recent clinical studies
demonstrated that collagen-based matrices can serve as an
alternative to autogenous tissue grafts for augmentation of
both the quality and the quantity of the soft tissues [9, 10].
These materials are considered a valuable treatment alterna-
tive [9, 11]. Soft tissue volume augmentation at pontic and
implant sites appears to be a challenging clinical situation with
a clear need for a soft tissue substitute. So far, no scientific
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evidence exists comparing the two most common collagen
matrices (with and without cross-linking) for contour augmen-
tation at pontic sites.
The aim of the present study was to assess histopathologic
and histomorphometric outcomes of soft tissue augmentation
procedures at pontic sites randomly using a volume-stable
cross-linked collagen matrix (VCMX), a non-cross-linked
collagen matrix (XCM), or a sham-operated control.
Materials and methods
Study design
The study was designed as a randomized controlled experi-
mental study employing 12 female beagle dogs at the age of
16–20 months, weighing 7–12.8 kg. The dogs were housed
under monitored laboratory conditions conforming with the
European requirements (EEC/2010/63). Dogs were fed a soft
diet during the entire study period. The study protocol was
approved by the local ethical committee of NAMSA (Lyon,
France) 189,735 and conducted in accordance with the OECD
Good Laboratory Practice regulations, ENV/MC/CHEM (98)
17, with the European Good Laboratory Practice regulations,
2004/10/EC Directive and with the United States Food and
Drug Administration Good Laboratory Practice regulations,
21 CFR 58.
Surgical interventions
All surgical procedures were performed under general anes-
thesia and under sterile conditions by two surgeons (DT, NN)
in an operating room. Premedication included antibiotics
(Buccoval, Sogeval, and Duplocilline, Intervent S.A) and pain
relief medication (Dorbene Vet, Zoetis, and Buprecare,
Axience). Prior to the surgery, the respective hemimandible
was disinfected with 0.2% chlorhexidine solution and the re-
gion was locally anesthetized using lidocaine hydrochloride
with adrenaline (Ubistesin forte, 3 M ESPE or Lidocaine
adrenaline, Aguettant). The respective surgical procedures
and the applied medication were described in detail in a pre-
vious publication (Thoma et al., 2017).
Extractions
Two premolars (P3, P4) and the first molar (M1) were treated
in each hemimandible of the dogs. The mesial roots were
carefully extracted, and the distal roots’ root-canal treated.
Soft tissue augmentation
After tooth extraction, soft tissue augmentation surgery was
performed at predefined healing periods (12, 30, or 34 weeks)
(Fig. 1). A mid-crestal full-thickness incision extending from
M1 to P4 and P3, respectively, as well as sulcular incisions at
the remaining roots (M1, P3, P4) were performed. Split-
thickness flaps were prepared, creating a pouch at the buccal
aspect of each site. Subsequently, the following three treat-
ment modalities were applied according to a predefined
computer-generated randomization table:
– VCMX, cross-linked volume-stable cross-linked porcine
collagen matrix (Fibro-Gide®, Geistlich Pharma AG,
Wolhusen, Switzerland)
– XCM, non-cross-linked porcine collagen matrix
(Mucograft®, Geistlich Pharma AG, Wolhusen,
Switzerland)
– Sham, incision and flap elevation without soft tissue
augmentation
The dimension of both the VCMX and XCMwere adapted
in length and width according to the size of the defect. A
thickness of 5 mm was ensured for both substitute products
prior to insertion. Both matrices were placed buccally in the
prepared pouch. Immobilization was ensured by applying a
single horizontal mattress suture at the lingual aspect.
Subsequently, primary and tension-free wound closure was
obtained by applying one horizontal mattress suture at the
center of the site. Additional single-interrupted sutures were
placed mesially and distally thereof (Fig. 2).
In order to end up with the predefined healing periods, soft
tissue augmentation in each dog was performed at two differ-
ent time-points (one per hemimandible) following the above
described protocol (Fig. 1).
After the surgical interventions, the dogs were fed a soft diet
and received antibiotics once a day (Buccoval, Sogeval) as well
as anti-inflammatory drugs (Carprodyl, CEVA) and local disin-
fection (CHX, Cooper) until suture removal 14 days later.
Thirty-eight weeks after tooth extraction/devitalization, all dogs
were euthanized by a lethal injection of a barbiturate (Dolethal,
Vetoquinol S.A., Paris, France). This corresponded to 4, 8, and
26 weeks of healing (after the tissue augmentation) (Fig. 1).
Histological preparation
After initial fixation and dissection of the hemimandibles (cut
with a band saw into one block per site), each block was ad-
ditionally fixated in 10% neutral buffered formalin. The blocks
were dehydrated in alcohol solutions of increasing concentra-
tion, cleared in xylene, and embedded in polymethylacrylate.
After transversal laser-sectioning into 4 samples (LLS
ROWIAK LaserLabSolutions GmbH, Hannover, Germany),
each block was stained with McNeal and afterward EXAKT
cutting was performed (approximately 30–40 um thick) and
the obtained slides were thereafter analyzed.
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Histopathologic and histomorphometric analysis
A qualitative and semi-quantitative evaluation of the his-
tologic sections under light microscopy (Nikon Eclipse
80i, Nikon, Tokyo, Japan) was performed in adaptation to
ISO 10993-6 and in compliance with the standard nomen-
clature of the International Society for Stereology. For the
histomorphometric outcomes assessment, the borders of
the prepared pouch were defined for each group. A vertical
line (corono-apical axis) and a horizontal line (bucco-
lingual axis) perpendicular to it were drawn from the top
of the lingual crest. Four additional horizontal lines were
drawn at different levels (1.5, 2.5, 3.5, and 5.5 mm) cov-
ering the entire augmented area. The ridge width was mea-
sured along these five lines for both bone tissue and aug-
mented soft tissue (Fig. 3).
Fig. 2 Soft tissue augmentation procedure. a Clinical situation after
initial healing period after tooth extraction; b preparation of the buccal
pouch; c soft tissue augmentation procedure for the respective groups:
sham, control (XCM), and test (VCMX). d clinical situation after primary
wound closure. Note the lingual suture in groups control and test to fixate
the graft to the lingual
Fig. 1 Timeline of the entire
study period with the respective
healing periods for elapsed time
after tooth extraction and time




Data were summarized in terms of mean, standard deviation,
and confidence interval. Macroscopic as well as the qualitative
and semi-quantitative histopathologic inflammatory parame-
ters were compared between the investigated groups. For each
group, comparisons between the different healing periods (4,
8, and 26 weeks) (Fig. 4) were calculated. Histopathologic
inflammatory parameters were described descriptively.
Based on the histopathologic and histomorphometric evalua-
tion, a statistical analysis was conducted (ANOVA (5% risk)
applying a statistical software (Software SSPS Version 24.0,
IBM, Zurich, Switzerland).
Results
Clinical and macroscopic findings
During the entire study period, the dogs remained healthy and
no systemic complications or local intolerances at the aug-
mented sites occurred.
Descriptive histology
After a healing period of 4 weeks, group VCMX demonstrat-
ed a higher amount of soft tissue at the augmented site com-
pared with group XCM. In addition, more pronounced fibro-
blast ingrowth and vascularization as well as a substantial new
collagen depositionwere observed in group VCMX compared
with group XCM. At 8 and 26 weeks of healing, group
VCMX presented with a greater overall amount of soft tissue
compared with XCM, while in both groups, a material degra-
dation had occurred. Over time, group XCM showed faster
signs of degradation compared with group VCMX. The sham
group healed without local inflammation and demonstrated no
visible soft tissue augmentation at all time-points.
Histomorphometric analyses
Four weeks after soft tissue augmentation, group VCMX
yielded a higher mean amount of augmented soft tissue com-
pared with groups XCM and sham at all measured levels. The
differences between VCMX and XCM (2.22 mm VCMX,
0.89 mm XCM (at 2.5 mm); 2.05 mm VCMX, 0.80 XCM
(at 3.5 mm)) and between VCMX and sham (2.24 mm
VCMX, 0.59 mm sham (at 1.5 mm); 2.22 mm VCMX,
0.48 mm sham (at 2.5 mm); 2.05 mm VCM, 0.44 mm sham
(at 3.5 mm)) reached statistically significant differences
(p < 0.05). At 8 weeks, group VMCX still yielded a greater
amount of augmented soft tissue compared with group XCM
at all levels without reaching statistical significance.
Compared with the sham group, values measured at 1.5 mm
(1.17 mm VCMX, 0.43 mm sham), 2.5 mm (1.15 mm
VCMX, 0.48 mm sham), and 5.5 mm (0.81 mm VCMX,
0.29 mm sham) reached statistical significance in favor of
group VCMX (p < 0.05). At 26 weeks of healing, group
VCMX had greater values of augmented soft tissue at all
measured levels compared with group XCMwithout reaching
statistical significance. Compared with group sham, group
VCMX reached significantly higher values (p < 0.05)
(1.11 mm VCMX, 0.39 mm sham (at 1.5 mm); 1.04 mm
VCMX, 0.47 mm sham (at 3.5 mm);0.90 mm VCMX,
0.14 mm sham (at 5.5 mm)) except for the level of 2.5 mm
(Table 1).
Discussion
The present preclinical study analyzing histologic and
histomorphometric outcomes following soft tissue augmenta-
tion applying two collagen matrices predominantly revealed
(i) a faster integration, vascularization, and fibroblast ingrowth
of VCMX at the earliest time-point (4 weeks) compared with
XCM; (ii) a more pronounced degradation at 8 and 26 weeks
in group XCM compared with group VCMX; and (iii) a
higher mean ridge width for group VCMX at all time-points
compared with groups XCM and sham.
Soft tissue volume augmentation is a frequently performed
muco-gingival procedure applied at pontic as well as at im-
plant sites. Due to an increased rate of patient morbidity when
using the gold standard, the autogenous soft tissue graft, re-
search has focused on soft tissue substitutes. Such devices
need to fulfill a number of criteria: fast integration into the
surrounding tissues with a minimal inflammatory reaction,
degradation and replacement by autogenous soft connective
tissue, and sustained stability of the augmented site. The ob-
served inflammatory reaction in the present study was mini-
mal in all groups. The histologic analysis showed stable re-
modeling processes and integration of both substitute mate-
rials over time. Similar healing and comparable histological
outcomes were also shown in a previous clinical study com-
paring XCM with a free gingival graft in an open-healing
approach [12]. Another previously published pre-clinical
study demonstrated a complete replacement of XCM by
healthy connective tissue within 30 days, leading to an opti-
mal integration of the substitute material [13]. In the present
study, vascularization and fibroblast ingrowth were more pro-
nounced in sites augmented with the cross-linked matrix at
4 weeks. Furthermore, a substantial new collagen deposition
was observed in this group which subsequently led to a more
pronounced gain of the augmented soft tissue area. In the non-
cross-linked collagen matrix groups, tissue integration was
delayed compared with group VCMX. The cross-linked struc-
ture of the investigatedmatrix seems to better mimic a scaffold
promoting increased cell-ingrowth compared with the non-
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cross-linked XCM if applied in a submerged setting.
Integration of the cross-linked collagen matrix after 1 month
was also shown in previous preclinical studies [3, 14]. It was
shown that the degree of cross-linking of the collagen-based
matrix correlated with an improved tissue integration. Not
only did previous investigations demonstrate favorable tissue
integration of the cross-linked matrix but also increased vas-
cularization and connective tissue formation [3, 15].
Comparing an autologous connective tissue graft to the
VCMX in a clinical study, histological analysis revealed good
integration of the cross-linked collagen matrix [11].
Along with a deposition and formation of collagen fibers
within the network structure of the twomatrices, both soft tissue
substitutes demonstrated variable degrees of degradation de-
pending on the time-point and matrix. At 4 weeks, degradation
was more pronounced in both collagen matrix groups, whereas
thereafter more stable remodeling processes were observed. In
addition, the group VCMX demonstrated a less distinct
degradation and a higher stability of the network structure com-
pared with groups XCM. This is in line with results from prior
preclinical studies demonstrating fast degradation of non-cross-
linked collagen membranes [16, 17]. The difference in network
structure between the two investigated collagen matrices has an
influence on degradation time, mechanical stability, and con-
nective tissue ingrowth [5, 14] . Both substitute materials have
been specifically developed for different clinical indications.
XCM is predominantly indicated for gain of keratinized tissue
and can be left exposed during healing, even though the matrix
has been applied for gain of soft tissue thickness in various
other indications. Since the main indication, however, is an
open-healing approach, the matrix is non-cross-linked. In con-
trast, VCMX is built up by cross-linked collagen and is indicat-
ed for procedures aiming at volume gain. Due to its porous
structure, VCMX is supposed to be placed in a submerged
approach. Furthermore, the cross-linked matrix facilitated early
vascularization and demonstrated network presence after
Fig. 3 a Histomorphometric
analysis. A vertical line (yellow)
and a horizontal line (green) were
drawn. Four additional horizontal
lines (blue) were drawn at differ-
ent levels (1.5, 2.5, 3.5, and
5.5 mm) covering the entire
augmented area. The ridge width
was measured along these five
lines for mineralized tissue, native
soft tissue, and augmented soft
tissue. b Superimposition of the
schematic illustration on a
histologic slide to provide an
overview of the measurements
carried out. The orange part of the
line represents the augmented soft
tissue
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24 weeks [18]. This is in line with the present study. Over time,
remodeling and degradation of the matrices was observed.
These processes led to a decrease of the augmented area be-
tween 2 and 6 months after augmentation both for VCMX and
autologous connective tissue grafts in a preclinical setting [3].
This is supported by contour measurements, resulting in a vol-
ume decrease for VCMX as well as for autogenous connective
tissue grafts in a preclinical study [19]. Results from the present
study revealed a decrease of the obtained soft tissue amount
mainly within the first 8 weeks (roughly 50%). This leads to
Fig. 4 Histologic slides showing the three groups (XCM, sham, and
VCMX) at different healing periods of 4, 8, and 26 weeks. All slides
stained with McNeal. High-resolution images on the right representing
the center of the augmented area (× 10 magnification). MT, mineralized
tissue; NST, native soft tissue; XCM, non-cross-linked collagen matrix;
VCMX, volume-stable cross-linked collagen matrix
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the speculation that an over-augmentation of the soft-tissuemay
be beneficial regarding the anticipated decline of the substitute
material. There is, however, no scientific evidence whether or
not such an over-augmentation would result in more favorable
outcomes.
The histomorphometrically assessed ridge width at the
three time-points did not result in an increased ridge width at
all time-points in the sham group. Groups XCM and VCMX
revealed higher values at 4 weeks compared with 8 and
26 weeks. Moreover, ridge width values were in favor of
group VCMX at all time-points. A randomized clinical trial
revealed that an autogenous connective tissue graft was more
effective than a non-cross-linked collagen matrix for improv-
ing soft tissue thickness [20].When comparing the clinical use
Fig. 4 (continued)
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of a cross-linked collagen matrix with an autologous connec-
tive tissue graft, the substitute material performed similar re-
garding soft tissue volume increase at implant sites [21].
These results might be explained by the difference in structure
of the cross-linked matrix. This provides an improved leading
structure for fibroblast ingrowth compared with a non-
crossed-linked matrix. The outcomes of the present study are
in line with the results from an earlier clinical study in which
the VCMX performed well and even surpassed the gold stan-
dard connective tissue graft regarding buccal volume augmen-
tation [11]. From a clinician’s and patient’s perspective, har-
vesting an autologous connective tissue graft from the palate
is time-consuming and associated with an increased patient



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a shorter surgical time and decreased patient morbidity [20].
In terms of patient-related outcomes, collagen matrix as a
substitute material seems to be a viable alternative in order
to avoid this negative effect.
Conclusions
The use of a volume stable cross-linked collagen matrix result-
ed in a greater and more stable ridge width over time compared
with a non-cross-linked collagen matrix when applied in a sub-
merged approach. Tissue integration as assessed by fibroblast
ingrowth was more favorable for the cross-linked collagen ma-
trix compared with the non-cross-linked collagen matrix.
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